Description
BAZ2A Antibody Polyclonal
| Catalog number: | B2016913 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 10 l |
| Molecular Weight or Concentration: | 270 kDa |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | TIP5, WALp3 |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Mayer C, Neubert M, Grummt I. The structure of NoRC-associated RNA is crucial for targeting the chromatin remodelling complex NoRC to the nucleolus EMBO Rep. 2008 Aug;9(8):774-80.
- Pea-Hernndez R, Aprigliano R, Carina Frommel S, Pietrzak K, Steiger S, Roganowicz M, Lerra L, Bizzarro J, Santoro R. BAZ2A-mediated repression via H3K14ac-marked enhancers promotes prostate cancer stem cells EMBO Rep. 2021 Nov 4;22(11):e53014.
- Dalcher D, Tan JY, Bersaglieri C, Pea-Hernndez R, Vollenweider E, Zeyen S, Schmid MW, Bianchi V, Butz S, Roganowicz M, Kuzyakiv R, Baubec T, Marques AC, Santoro R. BAZ2A safeguards genome architecture of ground-state pluripotent stem cells EMBO J. 2020 Dec 1;39(23):e105606.
- Roganowicz M, Br D, Bersaglieri C, Aprigliano R, Santoro R. BAZ2A-RNA mediated association with TOP2A and KDM1A represses genes implicated in prostate cancer Life Sci Alliance. 2023 Apr 25;6(7):e202301950.
- Dalle Vedove A, Cazzanelli G, Batiste L, Marchand JR, Spiliotopoulos D, Corsi J, DAgostino VG, Caflisch A, Lolli G. Identification of a BAZ2A-Bromodomain Hit Compound by Fragment Growing ACS Med Chem Lett. 2022 Aug 3;13(9):1434-1443.
- Cazzanelli G, Vedove AD, Parolin E, DAgostino VG, Unzue A, Nevado C, Caflisch A, Lolli G. Reevaluation of bromodomain ligands targeting BAZ2A Protein Sci. 2023 Sep;32(9):e4752.
- Dalle Vedove A, Cazzanelli G, Corsi J, Sedykh M, DAgostino VG, Caflisch A, Lolli G. Identification of a BAZ2A Bromodomain Hit Compound by Fragment Joining ACS Bio Med Chem Au. 2021 Dec 15;1(1):5-10.
- Spiliotopoulos D, Wamhoff EC, Lolli G, Rademacher C, Caflisch A. Discovery of BAZ2A bromodomain ligands Eur J Med Chem. 2017 Oct 20;139:564-572.
- Jia Y, Li L, Lin YH, Gopal P, Shen S, Zhou K, Yu X, Sharma T, Zhang Y, Siegwart DJ, Ready JM, Zhu H. In vivo CRISPR screening identifies BAZ2 chromatin remodelers as druggable regulators of mammalian liver regeneration Cell Stem Cell. 2022 Mar 3;29(3):372-385.e8.
